Dendritic cells matured by a prostaglandin E2-containing cocktail can produce high levels of IL-12p70 and are more mature and Th1-biased than dendritic cells treated with TNF-α or LPS

Immunobiology

Volumn 216, Issue 6, 2011, Pages 649-662

  Landi, Abdolamir ^a,d   Babiuk, Lorne A ^c   van Drunen Littel van den Hurk, Sylvia ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Human dendritic cell; IL 12; Maturation methods

Indexed keywords

CD83 ANTIGEN; CD86 ANTIGEN; CXCL16 CHEMOKINE; HLA DR ANTIGEN; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 15; INTERLEUKIN 27; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 4; PROSTAGLANDIN E2; PROTEIN CCL18; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANTIGEN PRESENTATION; ARTICLE; CELL MATURATION; CELL MOTILITY; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TRANSCRIPTION INITIATION; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; ADULT; CELLS, CULTURED; CULTURE TECHNIQUES; DENDRITIC CELLS; DINOPROSTONE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MALE; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 79955537176     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.11.004     Document Type: Article

References (81)

1. Abel S., Hundhausen C., et al. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J. Immunol. 2004, 172(10):6362-6372.
2. Ackerman A.L., Kyritsis C., et al. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc. Natl. Acad. Sci. U.S.A. 2003, 100(22):12889-12894.
3. Adema G.J., Hartgers F., et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 1997, 387(6634):713-717.
4. Banchereau J., Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 2005, 5(4):296-306.
5. Bonecchi R., Locati M., et al. Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor. J. Immunol. 2004, 172(8):4972-4976.
6. Bonifaz L., Bonnyay D., et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 2002, 196(12):1627-1638.
7. Borger P., Kauffman H.F., et al. Interleukin-15 differentially enhances the expression of interferon-gamma and interleukin-4 in activated human (CD4+) T lymphocytes. Immunology 1999, 96(2):207-214.
8. Boullart A.C., Aarntzen E.H., et al. Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E(2) results in high interleukin-12 production and cell migration. Cancer Immunol. Immunother. 2008.
9. Braun D., Longman R.S., et al. A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood 2005, 106(7):2375-2381.
10. Burns S., Hardy S.J., et al. Maturation of DC is associated with changes in motile characteristics and adherence. Cell Motil. Cytoskeleton 2004, 57(2):118-132.
11. Carayol N., Chen J., et al. A dominant function of IKK/NF-kappaB signaling in global lipopolysaccharide-induced gene expression. J. Biol. Chem. 2006, 281(41):31142-31151.
12. Carra G., Gerosa F., et al. Biosynthesis and posttranslational regulation of human IL-12. J. Immunol. 2000, 164(9):4752-4761.
13. Chen Z., Moyana T., et al. Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells. Int. J. Cancer 2001, 93(4):539-548.
14. D'Andrea A., Rengaraju M., et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 1992, 176(5):1387-1398.
15. Demali K.A. Vinculin-a dynamic regulator of cell adhesion. Trends Biochem. Sci. 2004, 29(11):565-567.
16. Dietz A.B., Bulur P.A., et al. Maturation of human monocyte-derived dendritic cells studied by microarray hybridization. Biochem. Biophys. Res. Commun. 2000, 275(3):731-738.
17. Dolganiuc A., Chang S., et al. Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J. Immunol. 2006, 177(10):6758-6768.
18. Elliott B., Scolyer R.A., et al. Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma. Clin. Cancer Res. 2007, 13(13):3825-3830.
19. Gaidano G., Bergui L., et al. Integrin distribution and cytoskeleton organization in normal and malignant monocytes. Leukemia 1990, 4(10):682-687.
20. Gilboa E. DC-based cancer vaccines. J. Clin. Invest. 2007, 117(5):1195-1203.
21. Godiska R., Chantry D., et al. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J. Exp. Med. 1997, 185(9):1595-1604.
22. Harding M.A., Theodorescu D. RhoGDI2: a new metastasis suppressor gene: discovery and clinical translation. Urol. Oncol. 2007, 25(5):401-406.
23. Harizi H., Gualde N. The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells. Tissue Antigens 2005, 65(6):507-514.
24. Hashimoto S.I., Suzuki T., et al. Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood 2000, 96(6):2206-2214.
25. Hofer S., Pfeil K., et al. Dendritic cells regulate T-cell deattachment through the integrin-interacting protein CYTIP. Blood 2006, 107(3):1003-1009.
26. Jefford M., Schnurr M., et al. Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli. Blood 2003, 102(5):1753-1763.
27. Jinushi M., Takehara T., et al. Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J. Immunol. 2003, 171(10):5423-5429.
28. Jonuleit H., Kuhn U., et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 1997, 27(12):3135-3142.
29. Ju X.S., Hacker C., et al. Towards determining the differentiation program of antigen-presenting dendritic cells by transcriptional profiling. Eur. J. Cell Biol. 2003, 82(2):75-86.
30. Kalayci O., Sonna L.A., et al. Monocyte chemotactic protein-4 (MCP-4; CCL-13): a biomarker of asthma. J. Asthma 2004, 41(1):27-33.
31. Kalinski P., Vieira P.L., et al. Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 2001, 97(11):3466-3469.
32. Kanaya S., Nemoto E., et al. Porphyromonas gingivalis lipopolysaccharides induce maturation of dendritic cells with CD14+CD16+ phenotype. Eur. J. Immunol. 2004, 34(5):1451-1460.
33. Krause P., Singer E., et al. Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO. J. Leukoc. Biol. 2007, 82(5):1106-1114.
34. Kuniyoshi J.S., Kuniyoshi C.J., et al. Dendritic cell secretion of IL-15 is induced by recombinant huCD40LT and augments the stimulation of antigen-specific cytolytic T cells. Cell. Immunol. 1999, 193(1):48-58.
35. Landi A., Babiuk L.A., et al. High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer. J. Leukoc. Biol. 2007, 82(4):849-860.
36. Landi A., Yu H., Babiuk L.A., van Drunen Littel-van den Hurk S. Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation. J. Viral Hepat. 2010 Aug 3. [Epub ahead of print] PMID: 20701679, http://www.ncbi.nlm.nih.gov/pubmed/20701679.
37. Langenkamp A., Messi M., et al. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 2000, 1(4):311-316.
38. Le Naour F., Hohenkirk L., et al. Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. J. Biol. Chem. 2001, 276(21):17920-17931.
39. Legler D.F., Krause P., et al. Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors. J. Immunol. 2006, 176(2):966-973.
40. Liao X., Li Y., et al. Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes. Mol. Ther. 2004, 9(5):757-764.
41. Lindstedt M., Johansson-Lindbom B., et al. Global reprogramming of dendritic cells in response to a concerted action of inflammatory mediators. Int. Immunol. 2002, 14(10):1203-1213.
42. Lucas M., Schachterle W., et al. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007, 26(4):503-517.
43. Luft T., Jefford M., et al. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood 2002, 100(4):1362-1372.
44. Luft T., Maraskovsky E., et al. Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cells. Blood 2004, 104(4):1066-1074.
45. Matloubian M., David A., et al. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat. Immunol. 2000, 1(4):298-304.
46. McIlroy A., Caron G., et al. Histamine and prostaglandin E up-regulate the production of Th2-attracting chemokines (CCL17 and CCL22) and down-regulate IFN-gamma-induced CXCL10 production by immature human dendritic cells. Immunology 2006, 117(4):507-516.
47. Mellman I., Steinman R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001, 106(3):255-258.
48. Messmer D., Messmer B., et al. The global transcriptional maturation program and stimuli-specific gene expression profiles of human myeloid dendritic cells. Int. Immunol. 2003, 15(4):491-503.
49. Morse M.A., Coleman R.E., et al. Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res. 1999, 59(1):56-58.
50. O'Doherty U., Steinman R.M., et al. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J. Exp. Med. 1993, 178(3):1067-1076.
51. Ohl L., Mohaupt M., et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 2004, 21(2):279-288.
52. Ohteki T., Tada H., et al. Essential roles of DC-derived IL-15 as a mediator of inflammatory responses in vivo. J. Exp. Med. 2006, 203(10):2329-2338.
53. Penna G., Vulcano M., et al. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum. Immunol. 2002, 63(12):1164-1171.
54. Pflanz S., Timans J.C., et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002, 16(6):779-790.
55. Platzer B., Jorgl A., et al. RelB regulates human dendritic cell subset development by promoting monocyte intermediates. Blood 2004, 104(12):3655-3663.
56. Randolph G.J., Beaulieu S., et al. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998, 282(5388):480-483.
57. Reis e Sousa C. Dendritic cells as sensors of infection. Immunity 2001, 14(5):495-498.
58. Rieser C., Bock G., et al. Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J. Exp. Med. 1997, 186(9):1603-1608.
59. Rubio M.T., Means T.K., et al. Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs. Int. Immunol. 2005, 17(12):1561-1572.
60. Savina A., Amigorena S. Phagocytosis and antigen presentation in dendritic cells. Immunol. Rev. 2007, 219:143-156.
61. Scandella E., Men Y., et al. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 2002, 100(4):1354-1361.
62. Scandella E., Men Y., et al. CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood 2004, 103(5):1595-1601.
63. Schuler-Thurner B., Schultz E.S., et al. Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J. Exp. Med. 2002, 195(10):1279-1288.
64. Schuler G., Schuler-Thurner B., et al. The use of dendritic cells in cancer immunotherapy. Curr. Opin. Immunol. 2003, 15(2):138-147.
65. Schulz O., Edwards A.D., et al. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 2000, 13(4):453-462.
66. Schunke D., Span P., et al. Cyclooxygenase-2 is a target gene of rho GDP dissociation inhibitor beta in breast cancer cells. Cancer Res. 2007, 67(22):10694-10702.
67. Shi G.X., Harrison K., et al. Toll-like receptor signaling alters the expression of regulator of G protein signaling proteins in dendritic cells: implications for G protein-coupled receptor signaling. J. Immunol. 2004, 172(9):5175-5184.
68. Snijders A., Kalinski P., et al. High-level IL-12 production by human dendritic cells requires two signals. Int. Immunol. 1998, 10(11):1593-1598.
69. Takashima A., Kitajima T. T cell-mediated terminal maturation of dendritic cells, a critical transition into fully potent antigen presenting cells. Pathol. Biol. (Paris) 1998, 46(1):53-60.
70. Ten Brinke A., Karsten M.L., et al. The clinical grade maturation cocktail monophosphoryl lipid A plus IFNgamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization. Vaccine 2007, 25(41):7145-7152.
71. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003, 3(2):133-146.
72. Tureci O., Bian H., et al. Cascades of transcriptional induction during dendritic cell maturation revealed by genome-wide expression analysis. Faseb J. 2003, 17(8):836-847.
73. Valentinis B., Capobianco A., et al. Human recombinant heat shock protein 70 affects the maturation pathways of dendritic cells in vitro and has an in vivo adjuvant activity. J. Leukoc. Biol. 2008, 84(1):199-206.
74. van Helden S.F., Krooshoop D.J., et al. A critical role for prostaglandin E2 in podosome dissolution and induction of high-speed migration during dendritic cell maturation. J. Immunol. 2006, 177(3):1567-1574.
75. Verdijk P., Aarntzen E.H., et al. Maximizing dendritic cell migration in cancer immunotherapy. Expert Opin. Biol. Ther. 2008, 8(7):865-874.
76. Vulcano M., Albanesi C., et al. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur. J. Immunol. 2001, 31(3):812-822.
77. Vulcano M., Struyf S., et al. Unique regulation of CCL18 production by maturing dendritic cells. J. Immunol. 2003, 170(7):3843-3849.
78. Wenink M., Santegoets K., van Bon L., Broen J., Huijbens R., Lubberts E., van Riel P., van den Berg W., Radstake T. Toll like receptor 2 promotes Th2/Th17 responses via TLR4 and TLR8 by human dendritic cells by abrogating the type 1 interferon amplification loop. Clin. Immunol. 2009.
79. Willimann K., Legler D.F., et al. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Eur. J. Immunol. 1998, 28(6):2025-2034.
80. Wilson N.S., Behrens G.M., et al. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 2006, 7(2):165-172.
81. Xia Y., Dai J., et al. Distinct effect of CD40 and TNF-signaling on the chemokine/chemokine receptor expression and function of the human monocyte-derived dendritic cells. Cell. Mol. Immunol. 2008, 5(2):121-131.